This week, Johnson & Johnson is proud to once again take a prominent position participating in the BIO International Convention. The annual meeting brings together colleagues from the Janssen Pharmaceutical Companies of Johnson & Johnson and Johnson & Johnson Innovation Centers who like many of the start-ups, academics, entrepreneurs, and industry and regulatory experts who attend, look forward to connecting with a noble purpose of collaborating and driving the future of healthcare.
As evidenced by our video that introduced the keynote speaker this year, Sir Richard Branson, we are propelled by the possibility of taking on urgent challenges, embracing collaboration and breaking through boundaries to shift treatment paradigms.
